{"id":112216,"date":"2023-10-19T03:44:27","date_gmt":"2023-10-19T03:44:27","guid":{"rendered":"https:\/\/dailytalks.org\/?p=112216"},"modified":"2023-10-19T03:44:27","modified_gmt":"2023-10-19T03:44:27","slug":"avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=112216","title":{"rendered":"Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US"},"content":{"rendered":"<p>Adelaide, Australia &#038; North Carolina, USA, Oct 19, 2023 &#8211; (ACN Newswire) &#8211; Avance Clinical, the Australian and North American market-leading CRO for biotechs, was asked to present their GlobalReady drug development solution to more than 45 Korean biotechs and pharmaceutical companies in Seoul, Korea last week as part of a special symposium at KoNECT Korea Conference.\u00a0&#8230;<br \/><a href=\"https:\/\/en.acnnewswire.com\/press-release\/english\/87133\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adelaide, Australia &#038; North Carolina, USA, Oct 19, 2023 &#8211; (ACN Newswire) &#8211; Avance Clinical,<\/p>\n","protected":false},"author":1,"featured_media":112217,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-112216","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-us-mrkt"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us-150x62.jpg",150,62,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/112216-avance-clinical-invited-to-brief-45-korean-biotechs-on-their-globalready-drug-development-pathway-from-korea-and-australia-to-the-us.jpg",220,62,false]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=25\" rel=\"category\">American Market<\/a>","tag_info":"American Market","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/112216","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=112216"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/112216\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/112217"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=112216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=112216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=112216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}